Types of Cancer We Treat

Glioma & Astrocytoma in Adults

We have experience in treating the most complex types of gliomas and astrocytomas. Our nationally known team of neurosurgeons, neuro-oncologists, radiologists, radiation oncologists, and neuropathologists partners to create a customized treatment plan for you.

Your team of specialists uses sophisticated diagnostic techniques, such as advanced MRI and precision molecular diagnosis, which determines the tumor’s specific molecular makeup.

Treatment may include targeted drugs, immunotherapy, and treatments provided through cutting-edge clinical trials. We also offer Gamma Knife® radiosurgery, a targeted treatment that provides an alternative to surgery and radiation therapy. Ultimately, we personalize a care plan just for you.

Meet Our Doctors
Neurosurgeon Dr. John Golfinos
Our Approach to Glioma & Astrocytoma in Adults Treatment Our Approach to Glioma & Astrocytoma in Adults Treatment
Diagnosis
Diagnosing Glioma and Astrocytoma
Surgery
Surgery for Glioma and Astrocytoma
Gamma Knife Radiosurgery
Gamma Knife Radiosurgery for Glioma and Astrocytoma
Radiation Therapy
Radiation Therapy for Glioma and Astrocytoma
Chemotherapy
Chemotherapy for Glioma and Astrocytoma
Immunotherapy
Chemotherapy for Glioma and Astrocytoma

Related News

Military Technology Aids Precision-Guided Neurosurgery
Read Story

Clinical Trials and Research Studies

Phase 1/2

Phase I-II Study of MEK 162 for Children with Low-Grade Gliomas and Other Ras/Raf/ERK Pathway Activated Tumors

Learn More

Phase 1/2

An Open-Label Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination with REGN2810 in Subjects with Newly-Diagnosed Glioblastoma (GBM)

Learn More

Phase 2

APEC1621C: NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Phase 2 Subprotocol of Tazemetostat in Patients with Tumors Harboring Alterations in EZH2 or Members of the SWI/SNF Complex

Learn More

Phase 2/3

A Phase 2/3 Randomized Open-Label Study of Toca 511 a Retroviral Replicating Vector Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA (Toca5)

Learn More
View All Related Clinical Trials (13)